[Induction of T cell responses against autologous ovarian cancer by anti-idiotype minibody-pulsed dendritic cells]
- PMID: 15601552
[Induction of T cell responses against autologous ovarian cancer by anti-idiotype minibody-pulsed dendritic cells]
Abstract
Background & objective: Immunotherapy of sensitizing dendritic cells (DCs) with antigen,protein,and frozen cancer cell has been widely used in treating various cancers. The 6B11 anti-idiotype-antibody,a fusion protein prepared by our research center,can mimic ovarian cancer-associated antigen OC166-9. This study was to induce T cell cytotoxicity against autologous tumor cells of patients with ovarian cancer by 6B11 anti-idiotype-antibody.
Methods: Peripheral blood samples were collected from 10 patients with epithelial ovarian cancer,Monocytes were isolated and cultured to obtain DCs. Immature DCs were stimulated with 6B11 anti-idiotype-antibody (MINI-DC group); unpulsed DCs (unpulsed-DC group),mouse F(ab) '2 fragments pulsed DCs [F(ab)'2-DC group],and T cells alone (T group) were served as controls. Mature DCs were harvested. (3)H-thymidine ((3)H-TdR) incorporation approach was used to measure effect of DCs on stimulating auto-T cell proliferation. Cytotoxicity of DC-activated T cells against auto-tumor cells was measured with (51)Cr 6-h release test,tumor cell lines,SKOV3,HLE,and K562, were used as controls.
Results: In 4 cases,cpm value of (3)H-TdR incorporation,as symbol of auto-T cell proliferation, in MINI-DC group was significantly higher than those in control groups. In 5 cases,specific cytotoxicity effect of T cells on auto-tumor cells was observed in MINI-DC group at effect-target ratio of 20:1,the toxicity effect of T cells in MINI-DC group was 25%-100%,significantly higher than those in F(ab)'2-DC group (18%-40%), unpulsed-DC group (13%-43%),and T group (9%-58%). In 4 cases,the toxicity effect of T cells in MINI-DC group, at effect-target ratio of 20:1,on auto-tumor cells was 25%-100%, higher than those on SKOV3 cells (5%-51%),HLE cells (2%-38%),and K562 cells (2%-25%). Moreover,the toxicity effect of T cells in MINI-DC group on auto-tumor cells can be partially blocked by anti-MHC-I antibody,which indicated that the toxicity was antigen-specific.
Conclusion: DCs loaded with 6B11 anti-idiotype antibody that mimic ovarian cancer antigen can induce antigen specific T cell cytotoxicity against auto-ovarian tumor cells in vitro.
Similar articles
-
Cytotoxic effects of T cells induced by fusion protein 6B11-pulsed dendritic cells on ovarian carcinoma cells.Gynecol Oncol. 2007 Apr;105(1):238-43. doi: 10.1016/j.ygyno.2006.04.028. Gynecol Oncol. 2007. PMID: 17383546
-
[Identification of T cell epitopes from ovarian cancer associated anti-idiotype antibody].Zhonghua Fu Chan Ke Za Zhi. 2008 Oct;43(10):764-9. Zhonghua Fu Chan Ke Za Zhi. 2008. PMID: 19087545 Chinese.
-
In vitro induction of tumor-specific human lymphocyte antigen class I-restricted CD8 cytotoxic T lymphocytes by ovarian tumor antigen-pulsed autologous dendritic cells from patients with advanced ovarian cancer.Am J Obstet Gynecol. 2000 Sep;183(3):601-9. doi: 10.1067/mob.2000.107097. Am J Obstet Gynecol. 2000. PMID: 10992180
-
[Monoclonal anti-idiotype antibodies in immunotherapy of ovarian carcinoma (MAb ACA125) and breast carcinoma (MAb ACA14C5)].Zentralbl Gynakol. 1999;121(4):190-5. Zentralbl Gynakol. 1999. PMID: 10355096 Review. German.
-
Novel immunotherapeutic strategies in gynecologic oncology. Dendritic cell-based immunotherapy for ovarian cancer.Minerva Ginecol. 2002 Apr;54(2):133-44. Minerva Ginecol. 2002. PMID: 12032451 Review.
Cited by
-
New T cell epitopes identified from an anti-idiotypic antibody mimicking ovarian cancer associated antigen.Cancer Immunol Immunother. 2008 Feb;57(2):143-54. doi: 10.1007/s00262-007-0354-8. Epub 2007 Jul 6. Cancer Immunol Immunother. 2008. PMID: 17618437 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Medical
Research Materials